Company Profile

Mediwave Star Technology Inc. is developing technologies which allow quantitative prediction of cardiac ischemia and risk for ventricular arrhythmia. The company's technology involves easily conducted, non-invasive testing of an individual during quasi-stationary exercise or other controlled cardiac stimulation. Certain data are collected while very gradual changes in the exercise or stimulation protocol precipitate changes in the individual's cardiac function and response. Those data are analyzed using proprietary MediWave algorithms; quantitative measures are generated; and those measures are compared against certain norms.